MphaR’s participation in the CAT-TCR event in London

March 21, 2026

In February, Natalia Denisova, PhD, Vice President, Head of Medical Affairs, and Sara Frau, PhD, Scientific Director Oncology, participated in the CAR-TCR event representing MphaR. Our team was very excited to be part of the CAR-TCR Summit in London.

In February Natalia Denisova, PhD, Vice President, Head of Medical Affairs, and Sara Frau, PhD, Scientific Director Oncology, participated in the CAR-TCR event representing MphaR. This congress was organized in F2F format for the first time in two years.

Natalia Denisova and Sara Frau at the MphaR stand

During this event, our team had a great opportunity to get and share knowledge in the area of CAR-TCR clinical trials. Dr Denisova presented how to overcome the recruitment challenges in CAR-T cell clinical trials.

The CAR-TCR event allowed MphaR team to meet and collaborate with many scientists and companies who aim to participate and develop the CAR-TCR therapy and improve the outcome of cancer patients. You can find more details in the interview to Rizwan Chaudhrey who was reporting from the scene.

MphaR was very excited to be part of the CAR-TCR Summit in London. We hope to develop established connections and collaboration. Our team is looking forward to participating in further events.

At MphaR, We Care About Our Planet and Its Future

We are committed to reducing CO2 emissions by minimizing travel activity in the pharmaceutical industry. As a partner of the OneTreePlanted program, MphaR continues to provide sustainable alternatives such as state-of-the-art digital platforms, reducing the need for industry professionals to travel.

MphaR’s participation in the CAT-TCR event in London

At MphaR, We Care About Our Planet and Its Future

Get Case Study

Get Brochure